What is Semax?
Semax is a synthetic heptapeptide with the amino-acid sequence Met-Glu-His-Phe-Pro-Gly-Pro. It corresponds to the 4-7 region of the adrenocorticotropic hormone (ACTH) fragment ACTH(4-10), extended with a Pro-Gly-Pro tripeptide that slows enzymatic breakdown. Importantly, Semax is non-corticotropic — it does not stimulate cortisol release the way ACTH does — and in the literature it is most often described as a nootropic and neuroprotective peptide studied in laboratory models.
Semax was developed by researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences, and the majority of the published work on it originates from that research tradition. Throughout this guide the compound is discussed strictly as a research material — it is intended exclusively for laboratory use and is not a medicine.
The essentials at a glance
ACTH(4-10)-derived heptapeptide
A stabilized, non-corticotropic analog of the ACTH(4-10) fragment with a Pro-Gly-Pro tail.
Neurotrophic angle
Research reports Semax regulates BDNF and its TrkB receptor in the hippocampus of model animals.
Research use only
Studied in cognition, neuroprotection, and stress models — never for human or animal use.
99%+ verified purity
HPLC-verified and confirmed by LC-MS, with a batch-specific certificate of analysis.
Explore research-grade Semax
HPLC-verified to 99%+ purity, batch-specific COA, fast U.S. shipping — for laboratory research use only.
View SemaxHow Semax is studied: mechanism in research models
As a short regulatory peptide, Semax has been examined across several parallel pathways. The recurring theme across the literature is its association with neurotrophic and monoaminergic signaling:
- BDNF / TrkB system — research has reported that a single application of Semax increases levels of brain-derived neurotrophic factor (BDNF) and activation of its TrkB receptor in the rat hippocampus.
- Neurotrophin gene expression — studies have described rapid, region-specific changes in BDNF and nerve growth factor (NGF) gene expression in the brain following administration.
- Monoaminergic systems — Semax has been investigated for modulatory effects on dopaminergic and serotonergic signaling in rodent brain regions.
This neurotrophic profile is the primary reason Semax draws research interest, and it is often the mechanism cited in studies of learning-related behavior and neuroprotection in model systems.
Semax and related research peptides
Semax is frequently discussed alongside Selank, another synthetic peptide from the same Russian research programs. Both are short, proline-rich peptides studied in neuroscience models, but they derive from different parent molecules and are characterized differently in the literature:
| Peptide | Sequence origin | Primary research framing | Class |
|---|---|---|---|
| Semax | ACTH(4-10) analog | Nootropic / neuroprotective models | Regulatory heptapeptide |
| Selank | Tuftsin analog | Anxiolytic / stress models | Regulatory heptapeptide |
| Melanotan II | ACTH(4-10)-related | Melanocortin-receptor research | Cyclic peptide analog |
Peptora carries research-grade versions of several related peptides, including Semax and Selank, each accompanied by its own batch-specific certificate of analysis.
What the research explores
In laboratory settings, Semax has most often been studied across a handful of interconnected areas:
- Cognition and memory — behavioral paradigms have been used to evaluate nootropic-like effects and learning-related changes in rodents.
- Neuroprotection — preclinical and some clinical research has examined Semax in ischemic and other stress-related brain models.
- Neurotrophic factors — BDNF, NGF, and their receptors have been measured as candidate mechanisms.
- Stress and mood models — chronic-stress paradigms have been used to characterize antistress-like effects in animals.
Purity, testing, and certificates of analysis
In research, the reliability of a result depends on the identity and purity of the material behind it. Every batch of Semax from Peptora is HPLC-verified to 99%+ purity, confirmed by LC-MS identity testing, and screened across a full quality-control panel before release. Each order ships with a lot-specific certificate of analysis (COA) so the material can be matched to its documentation.
Researchers often choose Peptora precisely because this documentation is standard rather than optional. To understand what each figure on a report means, see the guide on the certificate of analysis.
Handling Semax in the laboratory
Semax is supplied as a lyophilized (freeze-dried) powder. Before research use it is reconstituted with bacteriostatic water, which is sold separately. Proper handling preserves peptide integrity and the validity of downstream work:
- 1Allow the sealed vial to reach room temperature before opening.
- 2Add bacteriostatic water slowly against the vial wall; swirl gently and do not shake.
- 3Let the powder dissolve fully before drawing.
- 4Store the reconstituted solution refrigerated and protected from light.
Full step-by-step protocols live in the reconstitution guide. Following them consistently is one of the simplest ways to keep research reproducible.
Scientific references
Semax has been studied in cell-culture, animal, and some clinical research over roughly two decades. The literature below is provided for educational context, per PubMed, and describes model-system and clinical research on the compound — not the laboratory research product supplied by Peptora.
- 1Dolotov OV, Karpenko EA, Inozemtseva LS, et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006;1117(1):54-60. doi:10.1016/j.brainres.2006.07.108.
- 2Eremin KO, Kudrin VS, Saransaari P, et al. Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents. Neurochem Res. 2005;30(12):1493-1500. doi:10.1007/s11064-005-8826-8.
- 3Agapova TY, Agniullin YV, Shadrina MI, et al. Neurotrophin gene expression in rat brain under the action of Semax, an analogue of ACTH 4-10. Neurosci Lett. 2007;417(2):201-205. doi:10.1016/j.neulet.2007.02.042.
- 4Glazova NY, Manchenko DM, Volodina MA, et al. Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats. Neuropeptides. 2020;86:102114. doi:10.1016/j.npep.2020.102114.
- 5Inozemtseva LS, Yatsenko KA, Glazova NY, et al. Antidepressant-like and antistress effects of the ACTH(4-10) synthetic analogs Semax and Melanotan II on male rats in a model of chronic unpredictable stress. Eur J Pharmacol. 2024;984:177068. doi:10.1016/j.ejphar.2024.177068.
- 6Gusev EI, Martynov MY, Kostenko EV, et al. The efficacy of semax in the treatment of patients at different stages of ischemic stroke. Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(3 Vyp 2):61-68. doi:10.17116/jnevro20181183261-68.
Explore research-grade Semax
HPLC-verified to 99%+ purity, batch-specific COA, fast U.S. shipping — for laboratory research use only.
View SemaxKey takeaways
- Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro), a non-corticotropic analog of the ACTH(4-10) fragment.
- It has been investigated in research as a nootropic and neuroprotective peptide, most often in cognition and neuroprotection models.
- Published work reports that Semax regulates BDNF and its TrkB receptor and modulates dopaminergic and serotonergic signaling in model systems.
- Much of the literature originates from a single Russian research tradition and remains evolving rather than clinically established.
- Peptora's Semax is HPLC-verified to 99%+ purity with a lot-specific certificate of analysis, supplied for research use only.
Frequently asked questions
This article is intended solely as an educational summary of publicly available scientific literature. Products offered by Peptora are supplied exclusively for laboratory research purposes and are not approved for human or veterinary use. The information presented should not be interpreted as medical advice, treatment recommendations, or clinical guidance.






